• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    1/12/23 1:19:25 PM ET
    $ADCT
    $AGBA
    $APPH
    $ARBK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance
    Get the next $ADCT alert in real time by email

    Gainers

    • BigBear.ai Holdings, Inc. (NYSE:BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity contract by the U.S. Air Force.
    • Akerna Corp. (NASDAQ:KERN) climbed 54.4% to $1.4950 after the company announced the sale of 365 Cannabis for $2.8 million.
    • Expion360 Inc. (NASDAQ:XPON) rose 48.4% to $2.3450 after the company introduced AURA POWERCAP 600 and AURA POWERCAP 800, accessories that can transform Expion360 Li-ion batteries into a portable 600-watt or 800-watt powerpack.
    • Greenidge Generation Holdings Inc. (NASDAQ:GREE) gained 44% to $0.9459.
    • MultiMetaVerse Holdings Limited (NASDAQ:MMV) climbed 40.8% to $3.71 after the company announced a letter of intent to acquire a majority equity stake in Taomee.
    • Yield10 Bioscience, Inc. (NASDAQ:YTEN) shares gained 39.1% to $2.92 after the company reported it signed a MOU with Mitsubishi to evaluate the establishment of a partnership to supply, offtake and market Camelina as a low-carbon feedstock oil for biofuels.
    • Momentus Inc. (NASDAQ:MNTS) gained 38.8% to $1.2585 after the company signed a contract with FOSSA systems to place its FOSSASat FEROX satellites into low-Earth orbit.
    • Harbor Custom Development, Inc. (NASDAQ:HCDI) surged 38% to $0.6227.
    • The9 Limited (NASDAQ:NCTY) gained 35% to $1.06.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 32% to $5.12.
    • Bitfarms Ltd. (NASDAQ:BITF) jumped 31% to $0.9176. Shares of crypto-related stocks traded higher amid a rise in Bitcoin and Ethereum prices.
    • AppHarvest, Inc. (NASDAQ:APPH) gained 29.4% to $1.3850.
    • AGBA Group Holding Limited (NASDAQ:AGBA) rose 25.6% to $4.21.
    • Tantech Holdings Ltd (NASDAQ:TANH) gained 25% to $2.75.
    • Arrival (NYSE:ARVL) gained 25% to $0.34.
    • Helbiz, Inc. (NASDAQ:HLBZ) jumped 24.5% to $0.1650.
    • Werewolf Therapeutics, Inc. (NASDAQ:HOWL) gained 23% to $3.1633.
    • Argo Blockchain plc (NASDAQ:ARBK) rose 22.1% to $1.27. Argo Blockchain shares dropped 18% on Wednesday after the company announced a December operational update.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) gained 22% to $2.10.
    • LogicMark, Inc. (NASDAQ:LGMK) climbed 21.4% to $0.49.
    • ADC Therapeutics SA (NASDAQ:ADCT) shares jumped 21.1% to $5.17. IntoCell recently entered into development and license option agreement with ADC Therapeutics.
    • Arrival (NASDAQ:ARVL) rose 19.9% to $0.3237 after gaining around 9% on Wednesday.
    • IGM Biosciences, Inc. (NASDAQ:IGMS) gained 18.5% to $24.33.
    • Party City Holdco Inc. (NYSE:PRTY) rose 17.7% to $0.3337 after dropping 37% on Wednesday.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) climbed 16.9% to $6.27. Shares of crypto-related stocks traded higher amid a rise in Bitcoin and Ethereum prices.
    • Inuvo, Inc. (NASDAQ:INUV) gained 16.9% to $0.3099.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 14% to $3.9799 amid retail investor interest, high short interest and continued volatility following the company's recent layoffs and cost savings.
    • IGM Biosciences, Inc. (NASDAQ:IGMS) gained 13.6% to $23.33. IGM Biosciences recently announced update on IGM-8444 Phase 1 trial and future clinical development.
    • CommScope Holding Company, Inc. (NASDAQ:COMM) gained 12.5% to $8.43 after B of A Securities upgraded the stock from Underperform to Buy and raised its price target from $8 to $15.
    • Opera Limited (NASDAQ:OPRA) jumped 12.3% to $6.99. Opera declared special dividend of $0.80 per ADS.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) jumped 12.3% to $9.28.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares gained 7.9% to $4.3155. TC Biopharm 10% owner Edward Mark Randall bought a total of 70,000 shares at an average price of $5.00.
    • Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) surged 7.2% to $87.64 after the company reported better-than-expected Q4 EPS results.

     

    Losers

    • Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) shares dipped 76.7% to $2.51 after the company announced the ORA-D-013-1 trial did not meet its primary endpoint.
    • KNOT Offshore Partners LP (NYSE:KNOP) fell 37.8% to $6.53 after Alliance Global Partners downgraded the stock from Buy to Sell and announced a $6 price target.
    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) fell 25.1% to $7.55. Atlis Motor Vehicles recently reached 2 gigawatt-hours' worth of battery capacity in the form of customer demand.
    • Avaya Holdings Corp. (NASDAQ:AVYA) dropped 23.6% to $0.2508.
    • Universe Pharmaceuticals INC (NASDAQ:UPC) declined 23.2% to $0.9289.
    • TRxADE HEALTH, Inc. (NASDAQ:MEDS) fell 18.3% to $0.43 after jumping 34% on Wednesday.
    • Logitech International S.A. (NASDAQ:LOGI) fell 16.7% to $56.80 after the company reported preliminary Q3 Results and cut FY23 outlook.
    • Jaguar Health, Inc. (NASDAQ:JAGX) dropped 16.7% to $0.0962.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) declined 16% to $0.8940.
    • LianBio (NASDAQ:LIAN) dropped 15.4% to $2.1750. American Virtual Cloud Technologies filed for Chapter 11 bankruptcy.
    • Lipella Pharmaceuticals Inc.. (NASDAQ:LIPO) fell 12.8% to $3.20. Lipella Pharmaceuticals shares gained 18% on Wednesday after the company announced top line results of its Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis.
    • AMTD Digital Inc. (NYSE:HKD) dropped 12.4% to $11.56.
    • Biora Therapeutics, Inc. (NASDAQ:BIOR) fell 12.1% to $5.89 after climbing 24% on Wednesday. Biora Therapeutics has been granted U.S. patent number 11,547,301 titled "Methods For Collecting And Testing Bacteria Containing Samples From Within The Gastrointestinal Tract."
    • WW International, Inc. (NASDAQ:WW) fell 8.4% to $4.25.
    • Franchise Group, Inc. (NYSE:FRG) dropped 8.3% to $28.11.

    Also Check This Out ReWalk Robotics, American Resources And These 2 Penny Stocks Insiders Are Aggressively Buying

    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $AGBA
    $APPH
    $ARBK

    CompanyDatePrice TargetRatingAnalyst
    Alpha Tau Medical Ltd.
    $DRTS
    3/4/2026$5.00Overweight → Neutral
    Piper Sandler
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Taiwan Semiconductor Manufacturing Company Ltd.
    $TSM
    2/13/2026$450.00Buy
    DA Davidson
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Terns Pharmaceuticals Inc.
    $TERN
    2/9/2026$58.00Outperform
    Leerink Partners
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    Logitech International S.A.
    $LOGI
    1/20/2026Equal-Weight → Underweight
    Morgan Stanley
    Logitech International S.A.
    $LOGI
    1/16/2026$98.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $ADCT
    $AGBA
    $APPH
    $ARBK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alpha Tau downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Alpha Tau from Overweight to Neutral and set a new price target of $5.00

    3/4/26 8:30:52 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    DA Davidson initiated coverage on Taiwan Semiconductor Manufacturing with a new price target

    DA Davidson initiated coverage of Taiwan Semiconductor Manufacturing with a rating of Buy and set a new price target of $450.00

    2/13/26 8:32:20 AM ET
    $TSM
    Semiconductors
    Technology

    $ADCT
    $AGBA
    $APPH
    $ARBK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hayes Dorothy D sold $67,660 worth of shares (17,000 units at $3.98), decreasing direct ownership by 7% to 219,150 units (SEC Form 4)

    4 - BigBear.ai Holdings, Inc. (0001836981) (Issuer)

    3/6/26 4:22:43 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Ricker Sean Raymond covered exercise/tax liability with 18,725 shares and was granted 49,999 shares, increasing direct ownership by 7% to 512,138 units (SEC Form 4)

    4 - BigBear.ai Holdings, Inc. (0001836981) (Issuer)

    3/4/26 5:30:57 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    General Counsel and Secretary Blankenship Carolyn covered exercise/tax liability with 15,075 shares and was granted 36,143 shares, increasing direct ownership by 3% to 671,325 units (SEC Form 4)

    4 - BigBear.ai Holdings, Inc. (0001836981) (Issuer)

    3/4/26 5:29:55 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    $ADCT
    $AGBA
    $APPH
    $ARBK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney bought $643,464 worth of shares (29,057 units at $22.14) (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    11/20/25 4:01:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Chief Financial Officer Gengos Andrew bought $39,283 worth of shares (10,000 units at $3.93), increasing direct ownership by 67% to 25,000 units (SEC Form 4)

    4 - Terns Pharmaceuticals, Inc. (0001831363) (Issuer)

    6/30/25 5:38:10 PM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Burroughs Amy L. bought $90,230 worth of shares (23,314 units at $3.87), increasing direct ownership by 98% to 47,083 units (SEC Form 4)

    4 - Terns Pharmaceuticals, Inc. (0001831363) (Issuer)

    6/25/25 6:08:58 PM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $AGBA
    $APPH
    $ARBK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    $ADCT
    $AGBA
    $APPH
    $ARBK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place March 11–12, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here "We are delighted to highlight today's innovators from the Life Science

    3/10/26 10:21:44 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    AMTD Reached Deals on the Acquisition of a London Office Tower, in Conjunction with Amendment to Terms of Acquisition of the London Hornsey Town Hall Project, with Total Transaction Value at US$87.7 Million

    PARIS and NEW YORK and LONDON, March 10, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. (NYSE:HKD) and The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that AMTD IDEA Group  entered into a term sheet (the "Term Sheet") with FEC Property Holdings (UK) Limited ("the Office Seller") and FEC Finance Limited (the "Lender") pursuant to which, among others things, (i) AMTD IDEA Group agrees to acquire from the Office Seller an office building located at 40, Furnival Street, London, EC4A 1JQ (the "Office") at a consideration of approximately US$24.0 million (the "Office

    3/10/26 9:19:00 AM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update

    LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year-end 2026Recent amendment to HealthCare Royalty financing agreement increases strategic flexibilityFourth quarter and full year 2025 net product revenue of approximately $22.3M and $73.6M, respectively Cash and cash equivalents of $261.3M as of December 31, 2025, provide expected cash runway at least into 2028Company to host conference call today at 8:30 a.m. EDTLAUSANNE, Switzerland, March 10, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE:ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported financial results f

    3/10/26 7:30:00 AM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $AGBA
    $APPH
    $ARBK
    SEC Filings

    View All

    SEC Form S-3 filed by ADC Therapeutics SA

    S-3 - ADC Therapeutics SA (0001771910) (Filer)

    3/10/26 5:09:40 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by ADC Therapeutics SA

    10-K - ADC Therapeutics SA (0001771910) (Filer)

    3/10/26 4:36:47 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ADC Therapeutics SA filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ADC Therapeutics SA (0001771910) (Filer)

    3/10/26 7:58:12 AM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $AGBA
    $APPH
    $ARBK
    Financials

    Live finance-specific insights

    View All

    ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update

    LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year-end 2026Recent amendment to HealthCare Royalty financing agreement increases strategic flexibilityFourth quarter and full year 2025 net product revenue of approximately $22.3M and $73.6M, respectively Cash and cash equivalents of $261.3M as of December 31, 2025, provide expected cash runway at least into 2028Company to host conference call today at 8:30 a.m. EDTLAUSANNE, Switzerland, March 10, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE:ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported financial results f

    3/10/26 7:30:00 AM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026

    LAUSANNE, Switzerland, March 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE:ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Tuesday, March 10, 2026, at 8:30 a.m. EDT to report financial results for the fourth quarter and full year ended December 31, 2025, and provide operational updates. To access the conference call, please register here. The participant toll-free dial-in number is 1-800-836-8184 for North America and Canada. It is recommended that you

    3/3/26 7:15:00 AM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $ADCT
    $AGBA
    $APPH
    $ARBK
    Leadership Updates

    Live Leadership Updates

    View All

    Inuvo Appoints Rob Buchner as Chairman and Chief Executive Officer

    LITTLE ROCK, Ark., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE:INUV), a leading provider of artificial intelligence-driven data and advertising technology solutions, today announced the appointment of Rob Buchner as Chairman of the Board and Chief Executive Officer, effective February 1, 2026. Throughout 2025, Buchner worked closely within Inuvo in an advisory, board, and executive capacity. This experience has provided a comprehensive understanding of the company's existing markets, strategy, technology, and growth opportunities. Since joining the executive team as Chief Operating Officer in October of 2025, he has led a comprehensive review of talent, operations, product devel

    1/28/26 4:15:00 PM ET
    $INUV
    Advertising
    Consumer Discretionary

    Bitfarms Announces Board Chair Transition in Anticipation of U.S. Redomiciliation

    TORONTO, Ontario and NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX:BITF) ("Bitfarms" or the "Company"), a North American energy and digital infrastructure company, today announced that Edie Hofmeister has been appointed as Chair of the Board of Bitfarms. This appointment supports Bitfarms' previously announced strategy of redomiciling to the United States. Ms. Hofmeister succeeds Brian Howlett who has served as Director since 2020, and Chairman since 2024. Mr. Howlett will continue to serve as an Independent Director. Ms. Hofmeister brings over two decades of extensive expertise in legal affairs, corporate governance, and business strategy, developed over years in

    1/14/26 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Bed Bath & Beyond Appoints Nora Gomez as Chief Merchandising Officer

    Strategic hire strengthens focus on growth, margin expansion, and whole-home execution entering 2026 MURRAY, Utah and NASHVILLE, Tenn., Dec. 9, 2025 /PRNewswire/ -- Bed Bath & Beyond, Inc. (NYSE:BBBY) and The Brand House Collective, Inc. (NASDAQ:TBHC) today announced that Nora Gomez has been appointed Chief Merchandising Officer for Bed Bath & Beyond and its family of brands, driving unified product strategy and accountability across the entire portfolio. Gomez is a proven retail leader with over 20 years of experience in assortment strategy, global sourcing, and multi-channel

    12/9/25 7:30:00 AM ET
    $BBBY
    $TBHC
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores

    $ADCT
    $AGBA
    $APPH
    $ARBK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology